Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

Completed

Plain-English translation of NCT03546907 on ClinicalTrials.gov ↗ · Source last updated November 2022 · How we translate trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(83 sites)

United States

Investigational Site Number 8400002, Los Angeles, California

Investigational Site Number 8400003, Riverside, California

Investigational Site Number 8400006, Rolling Hills Estates, California

Investigational Site Number 8400015, Westminster, California

Investigational Site Number 8400013, Jacksonville, Florida